Page last updated: 2024-08-16

risperidone and fluphenazine

risperidone has been researched along with fluphenazine in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (9.30)	18.2507
2000's	21 (48.84)	29.6817
2010's	14 (32.56)	24.3611
2020's	4 (9.30)	2.80

Authors

Authors	Studies
Choudhary, MS; Craigo, SC; Meltzer, HY; Monsma, FJ; Roth, BL; Shen, Y; Sibley, DR; Uluer, A	1
Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S	1
Herrick-Davis, K; Purohit, A; Smith, C; Teitler, M	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J	1
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bauer, U; Gallhofer, B; Gruppe, H; Krieger, S; Lis, S	1
Morris, SE; Nuechterlein, KH; White, PM; Yee, CM	1
Conley, RR; Kelly, DL; Love, RC; Moore, DB; Sherr, JD	1
Miledi, R; Nguyen, QT; Yang, J	1
Marder, SR; Pierre, JM; Saunders, CS; Wirshing, DA; Wirshing, WC	1
Bilici, M; Cakirbay, H; Guler, M; Tan, U; Tosun, M; Ulgen, M	1
Conley, RR; Kelly, DL; Love, RC; McMahon, RP	1
Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M	1
Barna, I; Gazdag, G; Iványi, Z; Tolna, J	1
Conley, RR; Kelly, DL	2
McEvoy, JP	1
Arellano, A; Baptista, T; Beaulieu, S; Contreras, Q; Galeazzi, T; Hernández, L; Lacruz, A; Martinez, M; Mendoza, S; Vargas, D	1
Boshoven, W; Duncan, E; Dunlop, BW; Hamer, RM; Phillips, LS; Woolson, SL	1
Altshuler, LL; Bartzokis, G; Doi, C; Edwards, N; Gitlin, M; Lieu, C; Lu, PH; Mintz, J; Nuechterlein, KH	1
Ascher-Svanum, H; Marcus, SC; Olfson, M	1
Britvić, D; Ille, T; Stanković, Z; Vuković, O	1
Dziuba, J; Keshavan, M; Lachover, L; Manji, S; Pizzuti, A; Rajarethinam, R	1
Mihaljević-Peles, A; Mihanović, M; Sagud, M; Silić, A; Zivković, M	1
Citrome, L; Jaffe, A; Levine, J	1
Popović, I; Popović, V; Ravanić, D; Stanojević, A; Stojanović, M; Vladejić, S	1
Czernikiewicz, A; Kucharska-Pietura, K; Mortimer, A; Tylec, A	1
Chrisphonte, P; Ostroff, RB; Rosenheck, RA	1
Covell, NH; Essock, SM; Jackson, CT; McEvoy, JP; Rojas, IA; Schooler, NR; Stroup, TS	1
Kirk Morton, N; Zubek, D	1
Birkeland, SF	1
Furtado, VA; Li, BG; Sampford, JR; Sampson, S; Xia, J; Zhao, S	1
Dubin, WR; Fu, E; Kovach, JG	1
Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G	1
Osman, E; Yıldız, M	1
Fujii, Y; Misawa, F; Takeuchi, H	1
Akazawa, M; Inada, K; Okada, Y	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1

Reviews

4 review(s) available for risperidone and fluphenazine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Risks versus benefits of different types of long-acting injectable antipsychotics. The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 5 Topics: Administration, Oral; Antipsychotic Agents; Fluphenazine; Haloperidol; Health Care Costs; Humans; Injections, Intramuscular; Microspheres; Quality of Life; Risk Assessment; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Refusal	2006
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2016, Jul-02, Volume: 7 Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Benzodiazepines; Fluphenazine; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome	2016
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis. The American journal of psychiatry, 2021, 05-01, Volume: 178, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention	2021

Trials

8 trial(s) available for risperidone and fluphenazine

Article	Year
P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects. Journal of abnormal psychology, 1998, Volume: 107, Issue:4 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Anxiety; Attention; Cognition; Depression; Evoked Potentials; Female; Fluphenazine; Humans; Inhibition, Psychological; Longitudinal Studies; Male; Psychiatric Status Rating Scales; Risperidone; Schizophrenia	1998
Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. The International journal of neuroscience, 2002, Volume: 112, Issue:7 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bone Density; Clopenthixol; Clozapine; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia	2002
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics. International clinical psychopharmacology, 2004, Volume: 19, Issue:4 Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia	2004
Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:1 Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Female; Fluphenazine; Humans; Male; Middle Aged; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thyroid Diseases; Thyroid Function Tests; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine	2005
A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology, 2006, Volume: 31, Issue:3 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Female; Fluphenazine; Humans; Male; Middle Aged; Orgasm; Patient Compliance; Prolactin; Quetiapine Fumarate; Risperidone; Schizophrenia; Sexual Behavior; Sexual Dysfunction, Physiological	2006
Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia. Schizophrenia research, 2007, Volume: 89, Issue:1-3 Topics: Adult; Antipsychotic Agents; Appetite; Benzodiazepines; Blood Glucose; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Humans; Insulin; Insulin Resistance; Male; Olanzapine; Reference Values; Risperidone; Schizophrenia; Weight Gain	2007
First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. Psychiatria Danubina, 2011, Volume: 23, Issue:4 Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Substitution; Female; Fluphenazine; Haloperidol; Hospitalization; Humans; Long-Term Care; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Serbia; Treatment Outcome	2011
Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:5 Topics: Antipsychotic Agents; Connecticut; Delayed-Action Preparations; Drug Substitution; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Hyperprolactinemia; Injections; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Microspheres; Middle Aged; Patient Compliance; Proportional Hazards Models; Risperidone; Schizophrenia; Weight Gain	2012

Other Studies

31 other study(ies) available for risperidone and fluphenazine

Article	Year
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:3 Topics: Animals; Antipsychotic Agents; Cell Line; Molecular Structure; Rats; Receptors, Serotonin	1994
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:3 Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain	2003
Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs. Psychopharmacology, 2005, Volume: 179, Issue:2 Topics: Amino Acid Substitution; Antipsychotic Agents; Cell Line; Cyclic AMP; Humans; Mutagenesis, Site-Directed; Mutation; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors. European journal of medicinal chemistry, 2009, Volume: 44, Issue:6 Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship	2009
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1 Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1996, Volume: 6 Suppl 2 Topics: Clozapine; Cognition; Fluphenazine; Haloperidol; Humans; Maze Learning; Risperidone; Schizophrenia	1996
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Dec-15, Volume: 55, Issue:24 Suppl 4 Topics: Antipsychotic Agents; Baltimore; Chronic Disease; Delayed-Action Preparations; Disease-Free Survival; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Patient Readmission; Risperidone; Schizophrenia; Time Factors	1998
Effects of atypical antipsychotics on vertebrate neuromuscular transmission. Neuropharmacology, 2002, Volume: 42, Issue:5 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Fluphenazine; In Vitro Techniques; Membrane Potentials; Motor Endplate; Neuromuscular Junction; Olanzapine; Pirenzepine; Rana pipiens; Rana temporaria; Risperidone; Sulpiride; Synaptic Transmission	2002
Sexual side effects of novel antipsychotic medications. Schizophrenia research, 2002, Jul-01, Volume: 56, Issue:1-2 Topics: Adult; Antipsychotic Agents; Clozapine; Erectile Dysfunction; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior	2002
Rehospitalization risk with second-generation and depot antipsychotics. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2003, Volume: 15, Issue:1 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Data Collection; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Patient Readmission; Pirenzepine; Risperidone; Schizophrenia; Secondary Prevention; Time Factors; Treatment Outcome	2003
The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogyaszati szemle, 2004, Nov-20, Volume: 57, Issue:11-12 Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Brain; Clopenthixol; Clozapine; Dibenzothiazepines; Electric Impedance; Electroconvulsive Therapy; Electroencephalography; Electromyography; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Seizures; Sulpiride	2004
Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population. International clinical psychopharmacology, 2007, Volume: 22, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Chlorpromazine; Cohort Studies; Female; Fluphenazine; Haloperidol; Hospitals, Veterans; Humans; Hyperglycemia; Incidence; Male; Middle Aged; Olanzapine; Perphenazine; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Southeastern United States; Time Factors; Veterans	2007
Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophrenia research, 2007, Volume: 93, Issue:1-3 Topics: Adolescent; Adult; Antipsychotic Agents; Cohort Studies; Fluphenazine; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Reference Values; Risperidone	2007
Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone. Schizophrenia bulletin, 2007, Volume: 33, Issue:6 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Risperidone; Schizophrenia; Severity of Illness Index	2007
Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables. Psychiatria Danubina, 2008, Volume: 20, Issue:1 Topics: Administration, Oral; Adult; Age Factors; Ambulatory Care; Antipsychotic Agents; Clozapine; Cross-Sectional Studies; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Health Knowledge, Attitudes, Practice; Humans; Long-Term Care; Male; Middle Aged; Patient Compliance; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Yugoslavia	2008
Use of aripiprazole in tardive dyskinesia: an open label study of six cases. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia	2009
The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes. Psychiatria Danubina, 2010, Volume: 22, Issue:1 Topics: Adult; Alleles; Antipsychotic Agents; Bipolar Disorder; Clozapine; Cytochrome P-450 CYP2D6; Dibenzothiazepines; Drug Therapy, Combination; Fluphenazine; Genetic Carrier Screening; Genotype; Haloperidol; Humans; Lithium Carbonate; Male; Neuroleptic Malignant Syndrome; Perazine; Polymorphism, Genetic; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Recurrence; Risperidone	2010
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities. Schizophrenia research, 2010, Volume: 119, Issue:1-3 Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2010
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs. Medical science monitor : international medical journal of experimental and clinical research, 2012, Volume: 18, Issue:1 Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Attention; Benzodiazepines; Dibenzothiazepines; Emotions; Fluphenazine; Haloperidol; Humans; Memory; Middle Aged; Olanzapine; Perazine; Perphenazine; Quetiapine Fumarate; Recognition, Psychology; Risperidone; Schizophrenia; Sulpiride	2012
Perphenazine suspension: a new, old treatment, side effects and continuous use. The Psychiatric quarterly, 2012, Volume: 83, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cholinergic Antagonists; Clinical Trials as Topic; Drug Compounding; Drug Delivery Systems; Female; Fluphenazine; Haloperidol; Hospitals, Psychiatric; Humans; Male; Movement Disorders; Olanzapine; Patient Discharge; Perphenazine; Risperidone; Suspensions; Treatment Outcome	2012
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia. Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia	2013
Paranoid personality disorder and the schizophrenia spectrum-Where to draw the line? Personality and mental health, 2013, Volume: 7, Issue:3 Topics: Adult; Ambulatory Care; Antipsychotic Agents; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluphenazine; Hallucinations; Hospitalization; Humans; Paranoid Personality Disorder; Risperidone; Schizophrenia; Schizophrenic Psychology	2013
Priapism Associated With Antipsychotic Medication Use: Case Report. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:4 Topics: Antipsychotic Agents; Fluphenazine; Humans; Male; Middle Aged; Olanzapine; Priapism; Risperidone	2017
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2022,Summer, Volume: 33, Issue:2 Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine	2022
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan. The Journal of clinical psychiatry, 2022, 08-03, Volume: 83, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Risperidone; Schizophrenia; Tardive Dyskinesia	2022
Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan. Schizophrenia research, 2023, Volume: 252 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia	2023
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013